Dr. Heyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Fairfax, VA 22031Phone+1 571-472-4724
Summary
- David Heyer, MD, is an experienced oncologist based in Fairfax, VA. He specializes in Hematologic Oncology and holds several subspecialties in fields such as hematologic oncology, myeloproliferative disorders, lymphoma, myelodysplastic syndromes , and leukemia. His education spans the University of California in San Francisco where he did his fellowship and residency, and the University of Michigan Medical School where he graduated in 1985. Dr. Heyer has numerous publications under his name with his most recent works focusing on cancer care during the COVID pandemic. He has received several awards including the Meaningful Use Stage 1 Certification from Centers for Medicare & Medicaid Services and several recognitions from Castle Connolly, including Top Doctors in the Washington DC and Baltimore areas and Northern Virginia Magazine.
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1989 - 1991
- University of California (San Francisco)Residency, Internal Medicine, 1985 - 1989
- University of Michigan Medical SchoolClass of 1985
Certifications & Licensure
- CA State Medical License 1987 - Present
- VA State Medical License 1991 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsImmunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently in...Rui R. He, Zacharia Nayer, Matthew C. Hogan, Raymund S. Cuevo, Kimberly Woodward
Case Reports in Hematology. 2019-12-07 - 6 citationsRemote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study.Mary Steimer, Jessica Leabo, Hongkun Wang, David Heyer, Nancy Addison
JCO Oncology Practice. 2021-04-01 - Risk of COVID-19 in Patients With Cancer.Michael L. Maitland, David Heyer, Mardi Gomberg-Maitland
JAMA Oncology. 2020-09-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: